Login / Signup

Geographic variation of mutagenic exposures in kidney cancer genomes.

Sergey SenkinSarah MoodyMarcos Diaz-GayBehnoush Abedi-ArdekaniThomas CattiauxAida Ferreiro-IglesiasJingwei WangStephen FitzgeraldMariya KazachkovaRaviteja VangaraAnh Phuong LeErik N BergstromAzhar KhandekarBurçak OtluSaamin CheemaCalli LatimerEmily ThomasJoshua Ronald AtkinsKarl Smith ByrneRicardo Cortez Cardoso PenhaChristine CarreiraPriscilia ChopardValérie GaborieauPekka Keski-RahkonenDavid JonesJon W TeagueSophie FerlicotMojgan AsgariSurasak SangkhathatWorapat AttawettayanonBeata ŚwiątkowskaSonata JarmalaiteRasa SabaliauskaiteTatsuhiro ShibataAkihiko FukagawaDana MatesViorel JingaStefan RascuMirjana MijuskovicSlavisa SavicSasa MilosavljevicJohn M S BartlettMonique AlbertLarry PhouthavongsyPatricia Ashton-ProllaMariana Rodrigues BottonBrasil Silva NetoStephania Martins BezerraMaria Paula CuradoStenio de Cassio ZequiRui Manuel ReisEliney Ferreira FariaNei Soares de MenezesRenata Spagnoli FerrariRosamonde E BanksNaveen S VasudevDavid ZaridzeAnush MukeriyaOxana ShanginaVsevolod Borisovich MatveevLenka ForetovaMarie NavratilovaIvana HolcatovaAnna HornakovaVladimir JanoutMark P PurdueNathaniel RothmanStephen J ChanockPer Magne UelandMattias JohanssonJames McKayGhislaine SceloEstelle ChanudetLaura HumphreysAna Carolina de CarvalhoSandra PerdomoLudmil B AlexandrovMichael R StrattonPaul J Brennan
Published in: Nature (2024)
International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer burden 1 . In clear cell renal cell carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do not explain the geographical variation in its incidence 2 . Underlying causes can be inferred by sequencing the genomes of cancers from populations with different incidence rates and detecting differences in patterns of somatic mutations. Here we sequenced 962 clear cell renal cell carcinomas from 11 countries with varying incidence. The somatic mutation profiles differed between countries. In Romania, Serbia and Thailand, mutational signatures characteristic of aristolochic acid compounds were present in most cases, but these were rare elsewhere. In Japan, a mutational signature of unknown cause was found in more than 70% of cases but in less than 2% elsewhere. A further mutational signature of unknown cause was ubiquitous but exhibited higher mutation loads in countries with higher incidence rates of kidney cancer. Known signatures of tobacco smoking correlated with tobacco consumption, but no signature was associated with obesity or hypertension, suggesting that non-mutagenic mechanisms of action underlie these risk factors. The results of this study indicate the existence of multiple, geographically variable, mutagenic exposures that potentially affect tens of millions of people and illustrate the opportunities for new insights into cancer causation through large-scale global cancer genomics.
Keyphrases